BeOne Medicines Ltd
39 hedge funds and large institutions have $241M invested in BeOne Medicines Ltd in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 10 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
9% more capital invested
Capital invested by funds: $221M → $241M (+$20.3M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less funds holding
Funds holding: 41 → 39 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.1M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$4.68M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
+$2.25M |
| 4 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
+$2.18M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$1.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
-$2.93M |
| 2 |
VAM
Visium Asset Management
New York
|
-$2.92M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$2.11M |
| 4 |
ICP
Indus Capital Partners
New York
|
-$1.92M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$1.38M |
ONC Hedge Fund Activity: Q2 2016 in Review
39 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q2 2016, worth a combined $241M — up 9.2% from $221M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ONC and 8 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 10 added.
The largest buyer was Fidelity Investments, adding an estimated $17.1M. The largest seller was Light Street Capital Management, exiting entirely with an estimated $2.93M sold.
- 39 institutional investors held BeOne Medicines Ltd (ONC) as of Q2 2016, down from 41 in Q1 2016.
- Funds reported $241M of BeOne Medicines Ltd stock for Q2 2016, up 9.2% quarter-over-quarter.
- 8 funds opened new BeOne Medicines Ltd positions in Q2 2016 and 10 closed out, a net change of -2 holders.
- The largest BeOne Medicines Ltd buyer in Q2 2016 was Fidelity Investments, an estimated $17.1M added.
- The largest BeOne Medicines Ltd seller in Q2 2016 was Light Street Capital Management, an estimated $2.93M sold.
Based on aggregated 13F filings for Q2 2016.